| Jul 17 |
These Stock Winners Are ‘Strong Buys’ With More Room Left to Run
|
| Jun 28 |
Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
|
| Jun 24 |
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Jun 4 |
Soleno Therapeutics to join Russell 3000 Index
|
| Jun 4 |
Soleno Therapeutics Set to Join Russell 3000® Index
|
| May 29 |
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
|
| May 22 |
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
|
| May 22 |
Soleno Therapeutics to Participate in Upcoming Investor Conferences
|
